M3134

Monoclonal

Unmodified

IgG

WB, 1:1000-1:5000 | IHC, 1:200-1:1000 | IF, 1:200-1:1000 | IP, 0. 5μg-4μg antibody for 200μg-400μg extracts of whole cells. | ELISA, Recommended starting concentration is 1 µg/mL. Please optimize the concentration based on your specific assay requirements.

This antibody detects endogenous levels of Bad protein.

The antibody was purified by protein A affinity chromatography.

>>EGFR tyrosine kinase inhibitor resistance, >>Endocrine resistance, >>Platinum drug resistance, >>ErbB signaling pathway, >>Ras signaling pathway, >>cGMP-PKG signaling pathway, >>cAMP signaling pathway, >>Chemokine signaling pathway, >>Autophagy-animal, >>PI3K-Akt signaling pathway, >>Apoptosis, >>VEGF signaling pathway, >>Focal adhesion, >>Neurotrophin signaling pathway, >>Insulin signaling pathway, >>Thyroid hormone signaling pathway, >>Alzheimer disease, >>Amyotrophic lateral sclerosis, >>Prion disease, >>Pathways of neurodegeneration-multiple diseases, >>Toxoplasmosis, >>Tuberculosis, >>Hepatitis C, >>Hepatitis B, >>Measles, >>Human papillomavirus infection, >>Herpes simplex virus 1 infection, >>Human immunodeficiency virus 1 infection, >>Pathways in cancer, >>Viral carcinogenesis, >>Chemical carcinogenesis-receptor activation, >>Chemical carcinogenesis-reactive oxygen species, >>Colorectal cancer, >>Renal cell carcinoma, >>Pancreatic cancer, >>Endometrial cancer, >>Prostate cancer, >>Melanoma, >>Chronic myeloid leukemia, >>Acute myeloid leukemia, >>Non-small cell lung cancer, >>Hepatocellular carcinoma, >>Lipid and atherosclerosis

Q92934

BAD, BBC6, BCL2L8, Bcl2 antagonist of cell death, BAD, Bcl-2-binding component 6, Bcl-2-like protein 8, Bcl2-L-8, Bcl-XL/Bcl-2-associated death promoter